Tag Bengaluru

Bengaluru, 6th February 2024: Celebrating the spirit of love and beauty, Kryolan, a global professional cosmetics brand, is all set to paint the town red with an avant-garde Valentine’s Day Make-up Showcase and Masterclass Experience. Led by Ms. Sanah, a globally acclaimed make-up artist based out of Paris, France, this one-of-a-kind experience is set to take place on 14th February 2024 at the Kryolan City Bengaluru in Indira Nagar, promising an immersive fashion experience for aspiring make-up artists in beauty and high fashion and audiences alike.

With an impressive background in the TV and movie industry, as well as international high-profile events and festivals, Ms. Sanah is set to showcase three signature looks inspired by art from around the world that symbolize love in the truest sense. Attendees will have the privilege of witnessing the union of make-up, art, and fashion like no other and will also get to know the newest make-up trends from Ms. Sanah.

Kryolan’s Valentine’s Day Masterclass is open for both experienced and aspiring make-up artists wanting to learn Sanah’s techniques. For reservations and additional information, please contact +91 9500125626. Embrace the magic of make-up with us this Valentine’s Day and have an unparalleled experience.

Bengaluru, February 3, 2024: Fusion, a global leader in business process management (BPM) and customer experience (CX) solutions, proudly announced the opening of its new global facility in Navi Mumbai today. This significant development is part of Fusion’s extensive PAN India expansion strategy and demonstrates its commitment to enhancing service delivery and boosting employment opportunities in the region.

The launch of the Navi Mumbai facility is a landmark event for Fusion, signifying its consistent growth within the Indian market. The company plans to recruit over 500 professionals, elevating its workforce in India beyond the 10,000-employee mark.

Amitabh Vartak, Executive Vice President, Global Head of Healthcare & Life Sciences SBU, and Head of APAC operations, stated, “Mumbai’s dynamic energy and abundant talent pool make it a pivotal location for Fusion’s growth. Our expanded presence in Navi Mumbai strengthens our footprint in India and boosts our ability to serve our global clientele. It also gives us the capacity to service the increasing demand from our India-based clients. This strategic move significantly enhances our commitment to the Asian BPM industry and our reach in the global market.”

“This expansion is a strategic move towards strengthening our presence in APAC,” said Kishore Saraogi, Director, and Co-Founder of Fusion. “With the expansion of our Mumbai operations, we have established a strong presence in all four regions (North, East, South, West) in India. We aspire to transform the way businesses connect with their customers by blending human expertise, technology, and omnichannel support together.”

The newly inaugurated global facility is equipped with advanced technology, offering a range of services, including multilingual, omnichannel customer experience management, technical support, and back-office operations across various industries like Healthcare, BFSI, Hi-Tech, Retail, and Utilities.

Basab Bordoloi, Global Chief Human Resource Officer, expressed enthusiasm about the recruitment drive, stating, “We are eager to welcome talented individuals passionate about delivering transformational business process services with a maniacal focus on customer service. We will onboard over 500 people in the next quarter and bring the unique power of the human connect, AI-ML technologies, and service excellence to our global clientele.”

Bengaluru, February 3, 2024: Tata Motors Ltd. (TML) announced its results for quarter ending December 31, 2023.

 Tata Motors Consolidated:

TML delivered a strong performance in Q3 FY24 with Revenue of ₹110.6K Cr (up 25.0%), EBITDA at ₹15.8K Cr (up 60.6%) and EBIT of ₹9.2K Cr (+₹5.3K Cr) with all automotive verticals continuing their profitable growth trajectory. PBT (bei) improved by ₹4.4K Cr to ₹7.6K Cr and Net Profit was ₹7.1K Cr. For YTD FY24, the business reported strong PBT (bei) of ₹19.0K Cr, an improvement of ₹22.6K Cr over the previous year. Net Automotive debt reduced further to ₹29.2K Cr.

JLR revenue improved 22% to £7.4b. Improved wholesales and reduced material costs resulted in EBIT margins of 8.8% (+510bps). CV revenue improved by 19.2% and EBIT improved to 8.6% (+270bps) benefiting from higher realisations and richer mix. PV revenues were up by 10.6% and EBIT margins improved by 60 bps to 2.1% led by savings in commodity costs.

 Looking Ahead:

We remain positive on all three auto businesses. We expect the performance to further improve in Q4 on account of seasonality, new launches and improving supplies at JLR.  We achieved net debt reduction of ₹9.5K Cr in Q3 and we are confident of achieving our deleveraging plans.

 PB Balaji, Group Chief Financial Officer, Tata Motors said:

“It is satisfying to see our businesses execute well on their differentiated strategies and deliver a strong set of results for the quarter, thereby making it six quarters of consistent delivery. We aim to end the year on a strong footing and remain confident of sustaining our performance in the coming quarters and delivering on our de-leveraging plans.”   

Highlights

• Record Q3 FY24 and YTD FY24 revenue of £7.4 billion and £21.1 billion respectively.
• EBIT margin in Q3 FY24 of 8.8%; more than double Q3 FY23.
• PBT (bei) was £627 million in Q3 FY24, JLR’s highest quarterly profit since Q4 FY17. YTD FY24 PBT (bei) was £1.5 billion.
• Free cash flow was £626 million in Q3 FY24 and £1.4 billion for YTD FY24 and net debt reduced to £1.6 billion.
• Total liquidity was £5.8 billion, including the £1.52 billion undrawn revolving credit facility.

Reimagine Transformation

Modern Luxury

• Record quarterly Range Rover wholesales
• Range Rover Electric generating strong interest with over 15,000 sign ups to the waiting list since opening
• Sales of highest specification Range Rover SV with average price of £202,000, are growing year-on-year with 3,637 year-to-date sales already surpassing 1,909 Range Rover SV sold in FY23
• Defender 110 D300 X-Dynamic S wins What Car?  Car of the Year ‘Best seven-seater’ award

Electrification

• Range Rover Electric prototypes being tested on the road while electric medium size SUV prototypes and new Jaguar prototypes in development
• Transformation of JLR plants for EV production continues at pace:

o   New £60m BEV underbody line at Solihull, West Midlands, UK, being installed

o   New body shop in Halewood, Merseyside, UK, for electric EMA models near completion

o   Production lines for electric drive unit manufacture at Wolverhampton, West Midlands, UK progressing well

Sustainability

• ESG risk rating from Sustainalytics further improved, ‘Low Risk’ score reduced from 17.1 to 15.6, with ranking improving from the 4^th to the 3^rd lowest risk out of 74 companies in the Automotive Sub Industry

Financials

JLR delivered another strong performance in Q3 FY24, increasing wholesales to fulfil more client orders in the quarter. Revenue for the quarter was £7.4 billion, up 22% versus Q3 FY23 and up 8% versus Q2 FY24. Revenues for YTD FY24 were £21.1 billion – JLR’s highest ever revenue in the first nine months of a financial year and up 35% yoy. EBIT margin was positive at 8.8%, more than doubling from 3.7% a year ago. The higher profitability yoy reflects favourable volumes and reduced chip costs, offset partially by unfavourable fixed marketing, administration and FX revaluation.

 Looking ahead

The Company is on track to achieve its profitability and cashflow targets. The EBIT margin for FY24 is expected to be over 8% and we continue to expect operating cashflow to support net debt of less than £1 billion by the end of FY24 and positive net cash in FY25.

 Adrian Mardell, JLR Chief Executive Officer, said:

“We have delivered a further outstanding financial performance in quarter three, with our best quarterly profit for seven years and our highest ever revenue for the first nine months of a financial year. Sales of our modern luxury vehicles hit new records in the quarter and we are excited about the strong client interest for our soon to launch Range Rover Electric. I must attribute these results to our talented and dedicated people, who work relentlessly to bring our exceptional modern luxury cars to the market. Looking ahead, we are mindful of the challenges our business will face but are confident that we will continue to successfully deliver our Reimagine Strategy.”

 Highlights

• Q3 FY24 revenue at ₹ 20.1K Cr, (+19.2%), EBITDA 11.1% (+270 bps), EBIT 8.6% (+270 bps), PBT (bei) ₹ 1.7K Cr.
• YTD FY24 revenue at ₹ 57.2K Cr, (+15.4%), EBITDA 10.4% (+410 bps), EBIT 7.7% (+400 bps), PBT (bei) ₹ 4.1K Cr.
• Double-digit EBITDA delivered; continue to see sequential improvement.
• Domestic Vahan market share at 38.7% in Q3 FY24. HGV+HMV 50.7%, MGV 38.6%, LGV 32.4%, Passenger 35.1%.
• HGV+HMV market share increasing consistently this year. MGV market shares up 100bps qoq on better availability. Action plans underway to improve LGV market shares.
• Showcased a wide range of safer, smarter and greener mobility solutions at EXCON 2023. Unveiled advanced and comprehensive range of aggregates.
• Launched all-new Intra V70 pickup, Intra V20 Gold pickup and Ace HT making small commercial vehicles & pickups more efficient, functional, and productive with reduced ownership costs.
• Bagged the prestigious order of 1,350 diesel bus chassis from Uttar Pradesh State Road Transport Corporation.

 Financials

In Q3 FY24, domestic wholesale CV volumes were 91.9K units, marginally higher 1.1% yoy. Exports were at 4.8K units increasing by 14% yoy. However, revenues improved by 19.2% yoy to ₹20.1K Cr on account of salience towards medium and heavy commercial vehicles and better market operating price. The quarter witnessed strong EBITDA and EBIT margins of 11.1% (up 270 bps yoy) and 8.6% (up 270 bps yoy) respectively, due to improved pricing, superior mix, and strong realizations leading to a strong PBT (bei) of ₹1.7K Cr.

Looking ahead

Going forward, we expect demand to improve in Q4FY24 across most segments due to the Government’s continuing thrust on infrastructure development, the promising growth outlook of the economy and our demand-pull initiatives. We will continue to improve realizations whilst growing VAHAN share, drive innovation to address specific micro segment needs, focus on market development and scale up EV penetration. Focused actions are underway to win back the market share in SCVPUs. Profitability continues to remain the key focus area and we will strive to ensure consistent margin improvement and delivery of double-digit EBITDA margins.

Girish Wagh, Executive Director Tata Motors Ltd said:

“The CV industry witnessed a pause in sales growth in Q3FY24 on account of the higher base effect, impact of elections held across five states, and the post festive seasonal slowdown in rural consumption. While M&HCV and Passenger Commercial segments witnessed healthy growth, shrinking IL&CV and SCVPU sales pulled down overall volumes during the quarter.  Owing to pricing discipline and richer mix, profitability continued to improve and we achieved 11.1% EBITDA margins in Q3 FY24. We will continue to drive the business with strong customer connect, proactive demand-pull initiatives and with innovations in product and service. By improving customer affinity for our brands, we intend to further step-up registration market shares sustainably, and improve realisations and profitability.”

Bengaluru, February 03, 2024: Karnataka carries a staggering cancer burden, with the second highest reported rate among all Indian states covered by population-based cancer registries (PBCRs). Data reveals a staggering 151 cases per lakh population, mainly cervical ovarian and breast cancers which translates to a significant public health challenge.

Despite a rising burden, personalized medicine offers tailored therapy. Recently, India witnessed a beacon of hope in the form of precise cutting-edge treatments and personalised care approaches. For instance, standing at the forefront of precision therapy for cancer, is the newly introduced CAR-T cell therapy, NexCAR19. According to medical oncologists, this gene-modified cell treatment offers a single-infusion approach that significantly improves quality of life at a fraction of the global cost. The arrival of CAR-T program in Karnataka marks the start of a new era of personalized cancer care. It opens avenues for newer therapies and solutions for patients with relapsed or refractory B-cell lymphoma and B-acute lymphoblastic leukaemia.

A cancer diagnosis often comes with an overwhelming amount of information for patients to sift through and remember. In the intricate tapestry of cancer care, case managers emerge as vital navigators, offering a beacon of support for those traversing the challenging terrain of diagnosis and treatment. Medix Global, which offers a unique healthcare management model, further amplifies this support by offering its Personalised Cancer Care Case Management services as a pillar of support for patients and their families. “No two cancer journeys are identical,” says Medix Global’s Founder and CEO, Ms. Sigal Atzmon. “That’s why we tailor our services to each patient’s unique needs. We delve into medical history, personal circumstances, and treatment goals, crafting a precise, personalised care plan just for them. Ultimately, we aim to empower patients, navigating the intricate landscape of cancer care with compassion while leveraging both global and local expertise”, she said.

Medix Global aims at bringing in a fundamental change in how healthcare is delivered and consumed in India. Dr. Ankit Kumar Gupta, Senior Case Manager Doctor at Medix Global’s Mumbai Office emphasises on how their model is a movement away from a one-size-fits-all and fragmented approach towards more advanced, nuanced, patient-specific and holistic cancer care. “By implementing our uniquely managed care models across India, Medix flattens the inequality of care curve, reduces unwarranted healthcare variations between doctors, hospitals, cities, regions, countries and more, making quality healthcare borderless”, he said.

“The impact and improvement in medical outcomes that we have demonstrated speaks for itself”. Added Ms. Atzmon. “In 7.8% of the oncology cases managed, we changed the diagnosis and helped reach an accurate diagnosis. This includes, the type or subtype of cancer, staging of the tumour or extreme cases in which the patient was wrongly diagnosed and did not have cancer at all. In 54.1% of the cases, our specialists have recommended a different and more optimal, personalised treatment regimen. In 11.5% of the cases we helped, our patients avoid significant unnecessary treatment, procedures or surgery that was either not in line with the medical guidelines or not indicated for their condition.”

Personalised Cancer Management is crucial not just for better patient outcomes but also for the sustainability of healthcare systems at large. Such transformative approaches to healthcare shine as opportunities for individuals, insurers, employers and healthcare providers alike to ensure a healthier, more sustainable future.

Bengaluru, India, February 2nd, 2024: Elgi Equipments (BSE: 522074 NSE: ELGIEQUIP), one of the world’s leading air compressor manufacturers, today introduced the game-changing PG 550-215 trolley-mounted portable screw air compressor at the 12th edition of India Stonemart 2024 at the Jaipur Exhibition and Convention Centre (JECC), Rajasthan, India. Also displayed at the ELGi booth 6, in the outdoor machinery area B, were ELGi’s electric-powered PG110 E, PG 55 E, and PG 75 E portable air compressors for the mining industry. The 2024 edition of the International Stone Industry Trade Fair is expected to witness over 30,000 visitors and key decision-makers from the stone industry across the globe.

The newly introduced PG 550-215 is designed to deliver better performance, reliability, and profitability for customers in the construction and mining sectors. The compressor’s 3-stage air filtration system enables optimal performance while the integrated control panel ensures improved safety, reliability, and driller-friendly operations. The compressor’s Uptime design, which comprises large doors and a robust canopy, ensures easy maintenance, enhanced durability, and protection from extreme climatic conditions. In addition, ELGi’s pan-India network of service centers and trained service technicians ensure seamless operations for every customer.

The PG 110 E, 55 E, and 75 E series of electric-powered compressors, also on display, have been extensively adopted in standard pressure applications throughout the marble, granite, and blue metal quarries, where electricity is accessible and emission-free processes are required.

ELGi is committed to delivering high-performance portable compressed air solutions to construction and mining industry customers. With superior customer support and over 63 years of experience in compressed air technology, ELGi is today present across 120+ countries, offering a complete range of compressed air solutions from oil-lubricated and oil-free rotary screw compressors, oil-lubricated and oil-free reciprocating compressors and centrifugal compressors to dryers, filters, and downstream accessories. With state-of-the-art manufacturing units and a product portfolio of 400+ compressed air systems, ELGi redefines reliability, efficiency, and cost-effectiveness across 2+ million installations worldwide.

Bengaluru, February 2, 2024: After conducting successful Parent Engagement Programme (PEP) events at Raipur, Ahmedabad, Surat, and Rajkot with an overwhelming response from 200+ families, JAIN International Residential School (JIRS), is hosting its Parent Engagement Programme (PEP) in Bengaluru on Sunday 4th February 2024 at 7:00 pm at Hotel Royal Orchid, Golf Avenue, Domlur, Bengaluru.

 The main objective of the programme is to lay a common platform for both JIRS leadership team, alumni, prospective parents and students from the city, to engage with each other to understand the concept of residential schools, holistic education and the student development it offers.

 JIRS is all set to open its doors for parents and their wards of Bengaluru to experience the JIRS brand and its 25 years of legacy in creating global leaders. Bengaluru has been a key market for JIRS, from where they have moulded more than 1000+ students so far, into independent and strong personalities. About 120+ families are anticipated to attend the Parent Engagement Program in Bengaluru, according to JIRS.

 JIRS recently bagged the ‘No.1’ position in the Times School Survey 2023-2024. The ranking as the Top Residential School in Bengaluru is proof that JIRS is a complete residential school that offers the best of facilities to the students, comparable to global standards.

 Mr. Rudra Sharma – COO JIRS, said, “Following the enthusiastic feedback received from parents participating in various PEP programmes, we are excited to reveal the upcoming and final instalment of the Parent Engagement Programme series, concluding in Bengaluru. This programme provides parents with the opportunity to explore the full range of services offered by our school, fostering interaction with our esteemed alumni. Our aim is to nurture the growth of our student community amidst ongoing transformations, fostering internal development that will, in turn, contribute to our school’s global impact.”

 JIRS is recognised as a truly international standard school with students from across India and many other countries. Children are raised with strong roots of Indian culture and values, with international academic exposure, focusing on holistic development, in a homely gurukul environment with world class sprawling green pollution free campus.

 One of the key and important highlights at the JIRS campus is their world-class infrastructure facilities for sports. With an amalgamation of more than 30 playing areas for all major indoor and outdoor games, with qualified professional coaches training students for the national and international level, the school gives sports a dominant presence.

 JIRS ensures a great training environment with experienced fitness experts and participation in multiple school and national level tournaments which offer a perfect platform for the students to grow and develop a bright future. The complete boarding school concept makes children independent, bold, mentally, and emotionally strong, develops strong interpersonal relationship skills and makes them appreciate the diversity of children from various places and thoughts.

Bengaluru, India – 1 Feb 2024 – SAMCO Asset Management Private Limited, a leading investment management firm, is delighted to announce the reopening of India’s first actively managed momentum fund – SAMCO Active Momentum Fund. Following its initial launch and in light of the scheme’s proven performance and exceptional response from investors, SAMCO has decided to reopen the fund, providing investors with another opportunity to participate in this highly sought-after investment opportunity.

The SAMCO Active Momentum Fund is built upon the powerful investment strategy, aiming to deliver superior returns for investors by meticulously selecting stocks with momentum characteristics. The fund employs a proprietary momentum-seeking algorithm that identifies breakouts, price leadership, and other crucial momentum indicators.

The fund’s approach is rooted in the belief that by actively leveraging momentum characteristics, such as breakouts and price leadership, it can outperform the market and provide investors with an opportunity to capitalize on prevailing price trends.

Umeshkumar Mehta, Chief Investment Officer (CIO), SAMCO Asset Management Private Limited, said, ” Markets have entered a phase of slower momentum and increased volatility in the wake of upcoming local and global events. We want to use this opportunity to raise gunpowder (i.e. cash) so that when markets begin to accelerate, we are positioned to deploy efficiently to create superior wealth for our investors.”

Mr. Paras Matalia, Co-Fund Manager, SAMCO Asset Management Private Limited, said, “We are excited to reopen SAMCO Active Momentum Fund, providing investors with another opportunity to benefit from momentum investing. By reopening the fund for subscription, we aim to offer investors the chance to position their portfolios strategically and potentially achieve superior risk-adjusted returns.”

Commenting on the reopening, Viraj Gandhi, CEO, SAMCO Asset Management Private Limited, expressed, ” We strongly believe that momentum strategies should be a part of core portfolio allocations of investors seeking wealth creation. In India, active style of momentum investing continues to hold significant potential and offers tremendous advantages. We are pleased to offer investors another chance to participate in this strategy. “

The reopening of SAMCO Active Momentum Fund provides investors with the opportunity to subscribe again and position their portfolios to benefit from the Momentum factor.

Bengaluru, February 1, 2024: Pfizer and Glenmark Pharmaceuticals Ltd. (Glenmark) have joined hands to launch abrocitinib, a first-of-its-kind oral advanced systemic treatment for moderate-to-severe atopic dermatitis (AD), in India. Developed by Pfizer, abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India and is approved by the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regulatory agencies.

When launched in India, it will be co-marketed under the brand names JABRYUS® and CIBINQO® by Glenmark and Pfizer respectively. This collaboration combines the expertise of the companies to offer a groundbreaking treatment for moderate-to-severe AD, with improved efficacy and oral convenience to patients. Abrocitinib (CIBINQO) is available in over 35 markets globally, including the U.S., Japan, and China.

Atopic dermatitis is a chronic skin disease characterized by inflammation of the skin and skin barrier defects 1,2. The persistent itching associated with moderate-to-severe AD disrupts daily life, impacting social interactions, work productivity, and overall well-being. Abrocitinib, a Janus kinase 1 (JAK1) inhibitor, provides rapid itch relief, sustained disease control, and a vastly improved quality of life for patients3.

Meenakshi Nevatia, Country President and Managing Director of Pfizer India stated, “We believe in abrocitinib’s transformative potential. Its approval is a milestone in bringing high-quality treatment for moderate-to-severe atopic dermatitis in India, enabling patients to manage symptoms more effectively. Our collaboration with Glenmark will help leverage the collective strengths and capabilities of our organizations to make this breakthrough therapy available to patients and physicians across our country.”

Alok Malik, President and Business Head ‐ India Formulations, Glenmark Pharmaceuticals Ltd. said, “We are excited to collaborate with Pfizer India for the launch of abrocitinib in the country. The prevalence of atopic dermatitis in India has been reported to be increasing owing to changes in environmental factors with symptoms appearing during the initial years of life in around 80% of patients4. Being a leader in the dermatology therapy in India, this partnership will help us ensure availability of this effective treatment for the Indian patients suffering from moderate-to-severe AD; and further strengthen our position in the dermatology therapy space.”

Prevalence of AD in India

The prevalence of AD has been on the rise over the past three decades with an estimated prevalence of AD of about 10-20% in developed countries3. Approximately 5.9%5 of adults in India are affected by AD, of which 4.4%6 suffer from a severe form of this disease. The symptoms of AD like itching and lack of sleep, lay a significant burden on the patients and their caretakers, affecting multiple aspects including their quality of life and mental health3.

Bengaluru, February 1, 2024: Tata Motors, India’s leading automobile and mobility company, is exhibiting an impressive array of present and future ready vehicles and solutions designed to revolutionise personal mobility, people mobility, and cargo transport at the Bharat Mobility Global Expo 2024 being held from 1-3 February 2024 at the Bharat Mandapam, New Delhi.

 The Expo, a first-of-its-kind global mobility show in India, will have Tata Motors combine its inherent passion for ‘made in India’ and fundamental strength in engineering with expertise in human-centric design and new age innovation to showcase the future of mobility.

 On display will be Tata Motors’ vision, commitment and capability is making true the promise of tomorrow, today. Visit the Tata Motors Pavilion at stand H14-04 of the Bharata Mandapam (Pragati Maidan) to see:

• India’s 10 most advanced, efficient and eco-friendly Commercial Vehicles – Trucks, Buses, Tippers and Small trucks 
• India’s 8 greenest, smartest and most feature loaded Passenger Vehicles – Cars, SUVs and EVs
• Future-ready technologies – Hydrogen-powered internal combustion engines, twin cylinder CNG, efficient fuel delivery systems, battery electric powertrains and hydrogen fuel cell powered electric, to accelerate the adoption of clean and green mobility.
• Smart, tech-loaded vehicles – ADAS for enhanced safety, mobility solutions for public transport, Arcade.ev- app suite for gaming, entertainment and media, gesture operated control, and voice assistance.
• Digitally Connected Vehicles – Fleet Edge platform for efficient fleet management of commercial vehicles, ZConnect & IRA for enhanced convenience in personal mobility.
• Circular Economy – Re.Wi.Re for optimal recycling of end of life vehicles

Details of vehicles on display at stand H14-04 of the Bharata Mandapam (Pragati Maidan)

Bengaluru, January 31, 2024: Calligo is now set to be the first Company in the world to offer Posit-enabled Silicon.

   The semiconductor. Fabless Accelerator Lab (SFAL) is the premier Fabless accelerator in India and is supported by the Karnataka Information Technology Society, govt. Of Karnataka.

 Calligo Technologies, one of the companies incubated at SFAL is the first company to create posit arithmetic hardware implemented in the FPGA platform, Calligo has continued to pioneer technology by incorporating it into a general-purpose computing platform using an RISC-V design and has achieved the major milestone of successful tape out in Nov 2023 and the first silicon is expected to arrive in Feb 2024.

  Calligo is now once again set to be the first Company in the world to offer Posit-enabled. Silicon and well placed to bring out the end product– Accelerator Card for general-purpose computing. Calligo has a full software technology stack including an industry-compatible compiler and operating system, it is also enabling important HPC/AI applications.